POSLUMA
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for POSLUMA, covering 2023-05-25 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions [Phase 2]